Luis D. Medina

发表

1H MRS spectroscopy in preclinical autosomal dominant Alzheimer disease

John M. Ringman, J. Ringman, J. O’Neill, 2018, Brain Imaging and Behavior.

Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.

George Bartzokis, D. Geschwind, G. Bartzokis, 2007, Brain : a journal of neurology.

Brain lateralization of complex movement: Neuropsychological evidence from unilateral stroke

R. Solís-Vivanco, L. Medina, Luis D. Medina, 2014, Brain and Cognition.

Biochemical markers in persons with preclinical familial Alzheimer disease

D. Geschwind, J. Cummings, J. Ringman, 2008, Neurology.

Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease

D. Geschwind, J. Cummings, J. Ringman, 2013, Human brain mapping.

Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer’s Disease

J. Cummings, J. Ringman, G. Cole, 2012, Dementia and Geriatric Cognitive Disorders.

Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation

G. Small, L. Apostolova, A. Goate, 2011, Neuroscience Letters.

Cortical and Hippocampal Atrophy in Patients with Autosomal Dominant Familial Alzheimer’s Disease

Amity E. Green, D. Geschwind, P. Thompson, 2011, Dementia and Geriatric Cognitive Disorders.

Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease.

J. Cummings, P. Lu, J. Ringman, 2009, Current Alzheimer research.

Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations

P. Thompson, L. Apostolova, J. Ringman, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

The A431E mutation in PSEN1 causing Familial Alzheimer’s Disease originating in Jalisco State, Mexico: an additional fifteen families

J. Cummings, B. Ghetti, J. Ringman, 2006, Neurogenetics.

Impairment of memory generalization in preclinical autosomal dominant Alzheimer's disease mutation carriers

M. Gluck, C. Myers, J. Ringman, 2018, Neurobiology of Aging.

Reaction time and response inhibition in autosomal dominant Alzheimer’s disease

J. Ringman, H. Chui, H. Maldonado, 2020, Brain and Cognition.

Cortical event-related potentials in preclinical familial Alzheimer disease

R Irimajiri, E. Golob, A. Starr, 2009, Neurology.

Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task.

D. Geschwind, J. Cummings, J. Ringman, 2011, Cerebral cortex.

Increased fMRI signal with age in familial Alzheimer's disease mutation carriers

D. Geschwind, J. Cummings, J. Ringman, 2012, Neurobiology of Aging.

Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.

D. Geschwind, G. Bartzokis, J. Cummings, 2007, Brain : a journal of neurology.

Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation

G. Small, L. Apostolova, A. Goate, 2011, Neuroscience Letters.

Increased Prevalence of Significant Recurrent Headache in Preclinical Familial Alzheimer’s Disease Mutation Carriers

J. Ringman, A. Varpetian, Freddy Ortiz, 2008, Dementia and Geriatric Cognitive Disorders.

The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease.

J. Ringman, L. Medina, J. Grill, 2013, Contemporary clinical trials.

Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task.

D. Geschwind, J. Cummings, J. Ringman, 2011, Cerebral cortex.

Propositional Density and Apolipoprotein E Genotype among Persons at Risk for Familial Alzheimer’s Disease

Paul E. Gilbert, D. Geschwind, J. Cummings, 2011, Dementia and Geriatric Cognitive Disorders.